nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Discussion
|
|
|
1998 |
11 |
8S1 |
p. 109S-111S nvt p. |
artikel |
2 |
Discussion
|
|
|
1998 |
11 |
8S1 |
p. 135S-137S nvt p. |
artikel |
3 |
Discussion
|
|
|
1998 |
11 |
8S1 |
p. 127S- 1 p. |
artikel |
4 |
Disease management, pharmacoeconomics, and molecular biology
|
Materson, Barry J. |
|
1998 |
11 |
8S1 |
p. 101S-102S nvt p. |
artikel |
5 |
Health and disease management: what is it and where is it going?
|
Bernard, David B. |
|
1998 |
11 |
8S1 |
p. 103S-108S nvt p. |
artikel |
6 |
Number needed to treat: solid science or a path to pernicious rationing?
|
Black, HenryR |
|
1998 |
11 |
8S1 |
p. 128S-134S nvt p. |
artikel |
7 |
Pharmacoeconomics: what is it and where is it going?
|
McCombs, Jeffrey S. |
|
1998 |
11 |
8S1 |
p. 112S-119S nvt p. |
artikel |
8 |
The cost of treating hypertension
|
Moser, Marvin |
|
1998 |
11 |
8S1 |
p. 120S-127S nvt p. |
artikel |
9 |
Will angiotensin converting enzyme genotype, receptor mutation identification, and other miracles of molecular biology permit reduction of NNT?
|
Materson, Barry J. |
|
1998 |
11 |
8S1 |
p. 138S-142S nvt p. |
artikel |